<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="373117">
  <stage>Registered</stage>
  <submitdate>15/06/2017</submitdate>
  <approvaldate>14/09/2017</approvaldate>
  <actrnumber>ACTRN12617001320347</actrnumber>
  <trial_identification>
    <studytitle>Magnesium in open shoulder surgery</studytitle>
    <scientifictitle>Effect of Intravenous Magnesium on Post-operative Pain following Open Shoulder Surgery</scientifictitle>
    <utrn>U1111-1197-8555</utrn>
    <trialacronym />
    <secondaryid>Nil Known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Post-operative Pain</healthcondition>
    <healthcondition>Open Shoulder Surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients will be administered 50mg/kg of intravenous Magnesium Sulphate at a rate of less than 8g/hr immediately prior to surgery while monitored in the holding bay. This will take place over 30-60 minutes at the anaesthetists discretion. Magnesium sulphate infusion is an established therapy often used in intensive care and the obstetric patient suffering pre-eclampsia. Experience has shown it has a very safe side effect profile. Normal dosage given for previously mentioned indications is 40-50mg/kg. The recommended rate of administration is no greater than 8g per hour. Our regimen is in accordance with these guidelines. </interventions>
    <comparator>Intravenous normal saline. </comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Pain levels as determined by visual analogue pain scale.</outcome>
      <timepoint>Outcomes will be measured at 0, 6, 12, 18 and 24 hours.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Amount of analgesic medications required by review of the patients medical records post discharge and enquiring via telephone communication while at home. </outcome>
      <timepoint>At 0, 6, 12, 18 and 24 hours.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>These are patients scheduled for elective open shoulder surgery. </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients with a chronic pain syndrome, conduction defect or pacemaker, or inability to communicate VAS scoring due to language or miscomprehension will be excluded from this study.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation is not concealed</concealment>
    <sequence>Computerised sequence generation</sequence>
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate />
    <actualstartdate>25/04/2017</actualstartdate>
    <anticipatedenddate>1/07/2018</anticipatedenddate>
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <currentsamplesize>13</currentsamplesize>
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/07/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>The Avenue Private Hospital - Windsor</hospital>
    <postcode>3181 - Windsor</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>Melbourne Orthopaedic Group</primarysponsorname>
    <primarysponsoraddress>33 The Avenue, Windsor, Victoria</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other Collaborative groups</fundingtype>
      <fundingname>Melbourne Orthopaedic Group</fundingname>
      <fundingaddress>33 The Avenue, Windsor, Victoria, 3181</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Many patients who require surgery on the shoulder experience significant post operative pain,
particularly after their nerve block wears off. Despite the use of conventional analgesia many patients remain uncomfortable during this period. The aim of this project is to determine whether giving magnesium prior to surgery can improve this pain experience. The study proposes to give a single dose of magnesium to patients immediately prior to surgery and to assess their level of pain after surgery. This will involve the use of a subjective pain rating scale (1-10), and documentation of analgesic requirement. Patients will be randomly selected to receive either magnesium or placebo saline solution in order to assess the benefits of magnesium. Magnesium itself is a safe drug commonly used in clinical medicine for a number of different conditions.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Avenue Private Hospital Human Research and Ethics Committee</ethicname>
      <ethicaddress>40 The Avenue, Windsor, Vic 3181</ethicaddress>
      <ethicapprovaldate>22/04/2017</ethicapprovaldate>
      <hrec>EC00242</hrec>
      <ethicsubmitdate>6/12/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Alexander Morris</name>
      <address>St Vincent's Hospital Melbourne
41 Victoria Parade, Fitzroy, 3065, VIC</address>
      <phone>+61402196446</phone>
      <fax />
      <email>alexjohnmorris@outlook.com</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Alexander Morris</name>
      <address>St Vincent's Hospital Melbourne
41 Victoria Parade, Fitzroy, 3065, VIC</address>
      <phone>+61402196446</phone>
      <fax />
      <email>alexjohnmorris@outlook.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Alexander Morris</name>
      <address>St Vincent's Hospital Melbourne
41 Victoria Parade, Fitzroy, 3065, VIC</address>
      <phone>+61402196446</phone>
      <fax />
      <email>alexjohnmorris@outlook.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>